Compare ENR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENR | NVCR |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2015 | 2015 |
| Metric | ENR | NVCR |
|---|---|---|
| Price | $17.01 | $10.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $25.00 | ★ $28.08 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 6.96% | N/A |
| EPS Growth | ★ 538.46 | 21.79 |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $2,952,700,000.00 | $655,353,000.00 |
| Revenue This Year | $4.51 | $7.72 |
| Revenue Next Year | $1.07 | $6.74 |
| P/E Ratio | $5.19 | ★ N/A |
| Revenue Growth | 2.28 | ★ 8.28 |
| 52 Week Low | $16.38 | $9.82 |
| 52 Week High | $30.29 | $20.05 |
| Indicator | ENR | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 38.59 |
| Support Level | $16.76 | $10.86 |
| Resistance Level | $21.62 | $14.11 |
| Average True Range (ATR) | 0.56 | 0.53 |
| MACD | 0.06 | -0.15 |
| Stochastic Oscillator | 27.74 | 0.52 |
Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.